Cargando…
Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry
Purpose: To further investigate the safety and performance of the Passeo-18 Lux drug-coated balloon (DCB) for the treatment of atherosclerotic infrainguinal disease under real-world conditions. Materials and Methods: BIOLUX P-III is an international, prospective, observational registry (ClinicalTria...
Autores principales: | Tepe, Gunnar, Zeller, Thomas, Moscovic, Matej, Corpataux, Jean-Marc, Christensen, Johnny Kent, Keirse, Koen, Nano, Giovanni, Schroeder, Henrik, Binkert, Christoph A., Brodmann, Marianne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082893/ https://www.ncbi.nlm.nih.gov/pubmed/31989855 http://dx.doi.org/10.1177/1526602819898804 |
Ejemplares similares
-
Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry
por: Tepe, Gunnar, et al.
Publicado: (2020) -
Correction to: Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry
por: Tepe, Gunnar, et al.
Publicado: (2021) -
Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease
por: Müller-Hülsbeck, Stefan, et al.
Publicado: (2016) -
Drug-Coated Balloon Treatment of Femoropopliteal Lesions Typically Excluded From Clinical Trials: 12-Month Findings From the IN.PACT Global Study
por: Ansel, Gary M., et al.
Publicado: (2018) -
Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions: A Prospective Multicenter Observational Study
por: Walker, Craig M., et al.
Publicado: (2016)